$13.96-0.56 (-3.86%)
USANA Health Sciences, Inc.
USANA Health Sciences, Inc. in the Consumer Defensive sector is trading at $13.96 with a market capitalization of $261M. Wall Street consensus targets $25.00 (1 analysts), implying a +79.1% move over the next 12 months. The stock is currently near its 52-week low of $12.57, remaining 23.5% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $223.27Mβ | $250.22Mβ | $226.20Mβ | $213.67Mβ | $235.85M |
| Gross Profit | $174.93Mβ | $190.78Mβ | $176.79Mβ | $164.85Mβ | $185.66M |
| Operating Income | $9.14Mβ | $13.87Mβ | $17.25Mβ | $1.22Mβ | $16.72M |
| Net Income | -$21.38Mβ | $6.96Mβ | -$1.77Mβ | -$6.52Mβ | $9.65M |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. Th...